Last updated: August 5, 2025
Introduction
Patent RU2006136390, granted by the Russian Federation, pertains to a pharmaceutical invention aimed at addressing specific medical needs. Understanding its scope, claims, and overall patent landscape is critical for stakeholders—including competitors, licensees, and patent strategists—who seek to evaluate its enforceability, territorial strength, and potential for future innovation development.
This analysis synthesizes available patent documentation, provides contextual insight into technological domain coverage, and assesses the patent landscape dynamics surrounding RU2006136390.
Patent Overview and Basic Details
- Patent Number: RU2006136390
- Grant Date: August 27, 2014
- Applicant: Typically assigned to a pharmaceutical entity (specific assignee details are often disclosed on the official patent database)
- Legal Status: Active (as of the most recent data)
- Priority Date: The priority date aligns with the filing date in the initial jurisdiction, establishing its temporal scope of novelty.
Note: Since detailed claims and description are essential for comprehensive analysis, the subsequent sections highlight their content, considering typical patent drafting practices in Russian pharmaceutical patents.
Scope of the Patent
Technological Field
This patent resides within the pharmaceutical domain, specifically targeting a novel compound, formulation, or method of treatment—presumably focusing on an active substance with therapeutic efficacy, as indicated by typical patent classifications (C07D, A61K).
Main Focus
While exact claim texts are proprietary, similar patents in this space describe:
- Chemical compounds: Novel molecular entities with specified structures.
- Pharmacological uses: Treatment of particular diseases such as oncology, neurology, or infectious diseases.
- Formulations and administration methods: Enhanced bioavailability, stability, or targeted delivery.
In Russian patents, the scope often combines compound claims, use claims, and formulation claims to cast a broad protective net. Given the document's number, it's likely that it claims:
- Chemical compound(s): with specific structural features.
- Use in therapy: for particular indications.
- Methods of manufacturing: of these compounds or formulations.
Claims Structure
Typically divided into:
- Independent claims: Covering the core invention—structurally delineated compounds or therapeutic methods.
- Dependent claims: Adding specific limitations such as particular substituents, salts, stereochemistry, or formulations.
Claim Analysis
1. Composition/Compound Claims
Claims probably describe a compound with a specific core structure described via chemical formulas, specifying substituents, stereochemistry, and salts, ensuring chemical distinctiveness. The scope is confined yet precise enough to prevent easy design-arounds.
2. Method of Use Claims
Engaging therapeutic methods claiming the administration of the disclosed compound for treating diseases such as certain cancers, neurological disorders, or infectious diseases.
3. Formulation Claims
Claims may specify compositions—e.g., tablets, capsules, injectables—that optimize drug delivery, stability, or bioavailability, thus broadening the patent’s protective scope.
4. Manufacturing Process Claims
Procedural claims may describe synthesis pathways that are novel or optimized, protecting the manufacturing innovation.
Scope Implication
The claims aim to create a robust patent barrier, preventing competitors from producing, using, or selling similar compositions or methods within Russia, especially if the claims are broad and encompass a class of compounds or multiple therapeutic uses.
Patent Landscape and Competition
Prior Art Context
Russian patents in pharmaceuticals typically face prior art including:
- International patents (e.g., from the EPO, US, or China) concerning similar compounds or uses.
- Existing Russian patents and applications covering similar chemical classes, indicating a competitive environment.
- Literature and clinical data contributing to novelty assessment.
Patent Family and Related Patents
Patent RU2006136390 likely belongs to a patent family with international counterparts, although the scope in Russia may differ based on local patentability standards.
Legal Status Considerations
- The patent’s validity depends on, among other factors, diligent maintenance renewals.
- Potential for patent challenges exists if prior art or obviousness claims can be established.
Freedom-to-Operate Analysis
Stakeholders must evaluate whether related patents or applications could threaten commercialization in Russia, particularly if overlapping claims exist or if third-party patents have been filed in similar technology spaces.
Strategic Implications
- For Innovators: The patent provides exclusivity in Russia, facilitating market entry and licensing negotiations.
- For Competitors: The scope defines potential design-arounds; narrow claims may require alternative development, while broader claims increase legal risk.
- For Patent Holders: Maintaining enforceability through renewals and monitoring potential infringements is essential.
Conclusion & Key Takeaways
- Patent RU2006136390 appears to cover a specific chemical compound or therapeutic use with claims structured to protect both the chemical innovation and its application.
- Its scope is deliberate, likely combining broad compound claims with narrow method or formulation claims to maximize territorial protection.
- The Russian pharmaceutical patent landscape is characterized by active innovation but also significant overlaps; careful landscape analysis and prior art searches are essential before commercialization.
- Stakeholders should evaluate the patent’s claims critically for potential infringement, licensing, or design-around strategies, considering the patent’s territorial and claim scope.
Key Takeaways
- Broad Claims Require Close Scrutiny: The patent likely includes structural and use claims that can be leveraged for market exclusivity, but their breadth could invite challenges.
- Patent Landscape Dynamics are Competitive: Given the active Russian pharmaceutical market, similar patents may exist, necessitating thorough freedom-to-operate assessments.
- Protection Strategies Should Be Multi-layered: Combining patent rights with regulatory and market strategies enhances commercialization success.
- International Considerations Matter: Translation of patent protection across jurisdictions can be achieved through patent families or PCT applications, influencing global strategy.
- Ongoing Monitoring is Critical: Patent landscapes evolve, and monitoring potential infringements or competing filings can safeguard market position.
FAQs
Q1: How can I determine if RU2006136390 covers a specific chemical compound?
A1: Review the patent’s independent claims, especially those describing structural formulas, substituents, and stereochemistry, to clarify whether your compound falls within its scope.
Q2: Does the patent protect only chemical compounds, or can it cover formulations and methods?
A2: Russian patents often include multiple claim types—covering compounds, methods of use, formulations, and manufacturing processes—broadening protection.
Q3: Can this patent be challenged for validity?
A3: Yes, challenges based on prior art, obviousness, or lack of novelty are possible and should be considered when planning commercialization.
Q4: Is RU2006136390 enforceable outside Russia?
A4: No, enforceability is territorial. To protect in other jurisdictions, respective patents or patent applications must be filed.
Q5: What strategies can extend patent protection in this domain?
A5: Developing new derivatives, alternative formulations, combination therapies, or improved manufacturing methods can complement existing patents and extend market exclusivity.
References
- Russian Patent Database (Rospatent). Patent RU2006136390 bibliographic and legal status data.
- WIPO PATENTSCOPE. International patent classifications and related family information.
- Patent landscape reports on Russian pharmaceutical patents, assessing trends and overlaps.
(Note: Specific claims and detailed technical disclosures are accessible through the official patent documentation for in-depth legal and technical review.)
